- STAT+: ‘Secret shopper’ study probes GLP-1 telehealth sitesIn this edition of STAT Health Tech: A 'secret shopper' study of telehealth sites prescribing GLP-1s, news about Epic, Anthropic, and brain implants.STAT · 20d ago↗ source
- Vertex to acquire Crinetics in $10B foray into endocrine disease drugs<p>Vertex claimed the two drugs in the deal could eventually bring in more than $5 billion annually. Still, the high price it paid stirred debate among analysts and investors.</p>BioPharma Dive · 20d ago↗ source
- STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and moreVertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorderSTAT